64 - Moving Toward Broadly Reactive Influenza Vaccines

Speaker(s)

• 

  Julie Ledgerwood, Doctor of Osteopathic Medicine

  Deputy Director and Chief Medical Officer
  Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Stacey Schultz-Cherry, PhD

  Full Member (Professor)
  St Jude Children's Research Hospital
  Memphis, Tennessee

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• CW

  Chris Woods, M.D.

  Professor
  Duke University School of Medicine
  Durham, North Carolina

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Learning Objectives:

• examine advances to inform development of broadly reactive influenza vaccines

Presentations:

• 2:45pm – 4:00pm EDT

  COVID-19 Vaccine Development
  Julie Ledgerwood, Doctor of Osteopathic Medicine – Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health
• 2:45pm – 4:00pm EDT

  Influenza Challenge Studies: What Can We Learn?
  Chris W. Woods, M.D. – Duke University School of Medicine
• 2:45pm – 4:00pm EDT

  Moving Towards Improved Influenza Vaccines (antigen Discovery and Novel Adjuvants)
  Stacey Schultz-Cherry, PhD – St Jude Children's Research Hospital